The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA
- PMID: 2068104
- PMCID: PMC52057
- DOI: 10.1073/pnas.88.14.6234
The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA
Abstract
The basic domain of Tat is required for trans-activation of viral gene expression. We have performed scanning peptide studies to demonstrate that only this domain is capable of binding to the TAR RNA stem-loop. Strikingly, the basic domain of the other human immunodeficiency virus trans-acting factor, Rev, but no other region, is also capable of binding to TAR. Peptide derivatives of Tat do not require the highly conserved glutamine residue at position 54 for TAR binding, since it may be substituted or deleted. In addition, the two lysine residues may be replaced by arginines. Analysis of binding and trans-activation demonstrated that homopolymers of arginine can completely substitute for the basic domain. Such homopolymers have high affinity for wild-type TAR RNA and lower affinity for mutant TAR. Homopolymers of six to nine arginines substituting for the basic domain of Tat enable full trans-activation in vivo. Homopolymers of at least seven arginines are required for detectable in vitro complex formation, although approximately 30% trans-activation is achieved with a mutant Tat containing only five arginines.
Similar articles
-
The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.Genes Dev. 1992 Nov;6(11):2077-87. doi: 10.1101/gad.6.11.2077. Genes Dev. 1992. PMID: 1427073
-
Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.J Virol. 1993 Sep;67(9):5617-22. doi: 10.1128/JVI.67.9.5617-5622.1993. J Virol. 1993. PMID: 8350414 Free PMC article.
-
Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR.J Virol. 1993 Jun;67(6):3441-5. doi: 10.1128/JVI.67.6.3441-3445.1993. J Virol. 1993. PMID: 8497060 Free PMC article.
-
RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.Biochemistry (Mosc). 1998 May;63(5):489-503. Biochemistry (Mosc). 1998. PMID: 9632883 Review.
-
HIV-1 Tat amino acid residues that influence Tat-TAR binding affinity: a scoping review.BMC Infect Dis. 2023 Mar 17;23(1):164. doi: 10.1186/s12879-023-08123-0. BMC Infect Dis. 2023. PMID: 36932337 Free PMC article.
Cited by
-
Exosomal packaging of trans-activation response element (TAR) RNA by HIV-1 infected cells: a pro-malignancy message delivery to cancer cells.Mol Biol Rep. 2019 Jun;46(3):3607-3612. doi: 10.1007/s11033-019-04770-2. Epub 2019 Mar 22. Mol Biol Rep. 2019. PMID: 30903574 Review.
-
Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.J Virol. 1996 Sep;70(9):5777-85. doi: 10.1128/JVI.70.9.5777-5785.1996. J Virol. 1996. PMID: 8709193 Free PMC article.
-
The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.J Virol. 1994 Oct;68(10):6188-97. doi: 10.1128/JVI.68.10.6188-6197.1994. J Virol. 1994. PMID: 8083959 Free PMC article.
-
Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein.Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7719-23. doi: 10.1073/pnas.90.16.7719. Proc Natl Acad Sci U S A. 1993. PMID: 7689227 Free PMC article.
-
Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ.J Virol. 1997 Apr;71(4):3188-96. doi: 10.1128/JVI.71.4.3188-3196.1997. J Virol. 1997. PMID: 9060682 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources